arginine has been researched along with razoxane in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (50.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, SK; Slavik, M | 1 |
| Grieder, A; Maurer, R; Stähelin, H | 1 |
| Pawlicki, M; Zuchowska-Vogelgesang, B | 1 |
| Campbell, ED; Carter, WH; Stablein, DM; Wampler, GL | 1 |
| Holm, B; Jensen, PB; Sehested, M | 1 |
| Beck, WT; Mo, YY | 1 |
| Beck, WT; Khélifa, T | 1 |
| Abd-Allah, AR; Al-Harbi, MM; Al-Khedhairy, AA; Al-Rasheed, NM; Ashour, AE; Attia, SM; Bakheet, SA; Korashy, HM; Musarrat, J; Saquib, Q | 1 |
2 review(s) available for arginine and razoxane
| Article | Year |
|---|---|
Investigational drugs under study by the United States National Cancer Institute.
Topics: Acrylates; Alkylating Agents; Ancitabine; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Chemical Phenomena; Chemistry; Chromomycins; Cisplatin; DNA, Neoplasm; Drug Evaluation, Preclinical; Etoposide; Humans; Ifosfamide; Leukemia L1210; Mice; Mitosis; National Institutes of Health (U.S.); Neoplasms; Neoplasms, Experimental; Razoxane; Tegafur; Teniposide; United States | 1976 |
[New antineoplastic agents, their value and use].
Topics: Aminacrine; Antineoplastic Agents; Aspartic Acid; Cisplatin; Etoposide; Humans; Ifosfamide; Interferons; Medroxyprogesterone; Medroxyprogesterone Acetate; Methyltestosterone; Neoplasms; Phosphonoacetic Acid; Razoxane; Tamoxifen; Teniposide; Vinca Alkaloids | 1982 |
6 other study(ies) available for arginine and razoxane
| Article | Year |
|---|---|
Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
Topics: Antineoplastic Agents; Bleomycin; Cell Division; Cell Line; Colchicine; Cytarabine; DNA, Neoplasm; Etoposide; Mast-Cell Sarcoma; Mechlorethamine; Mercaptopurine; Methotrexate; Mitosis; Neoplasm Proteins; Neoplasms, Experimental; Podophyllotoxin; Razoxane; RNA, Neoplasm; Teniposide; Vincristine; X-Rays | 1977 |
Drug activity and therapeutic synergism in cancer treatment.
Topics: Animals; Antineoplastic Agents; Dacarbazine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Melanoma; Mice; Mitomycin; Mitomycins; Neoplasms; Neoplasms, Experimental; Rats; Razoxane; Teniposide | 1982 |
Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug Administration Schedule; Etoposide; Female; Mice; Mice, Inbred Strains; Razoxane; Survival Rate; Teniposide; Topoisomerase II Inhibitors | 1998 |
DNA damage signals induction of fas ligand in tumor cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; CHO Cells; Cricetinae; DNA; DNA Damage; Doxorubicin; Enzyme Inhibitors; Etoposide; Fas Ligand Protein; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Jurkat Cells; Membrane Glycoproteins; Nucleic Acid Synthesis Inhibitors; Promoter Regions, Genetic; Razoxane; Recombinant Fusion Proteins; Signal Transduction; Teniposide; Thiobarbiturates; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Up-Regulation | 1999 |
Induction of apoptosis by dexrazoxane (ICRF-187) through caspases in the absence of c-jun expression and c-Jun NH2-terminal kinase 1 (JNK1) activation in VM-26-resistant CEM cells.
Topics: Antineoplastic Agents; Apoptosis; Asparagine; Calcium-Calmodulin-Dependent Protein Kinases; Caspases; Cell Division; Drug Resistance, Neoplasm; Enzyme Induction; Enzyme Inhibitors; Gene Expression; Humans; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-jun; Razoxane; Signal Transduction; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1999 |
Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells.
Topics: Animals; Apoptosis; Bone Marrow Cells; Caspase 3; Cell Cycle; Chromosomes, Mammalian; DNA Breaks; DNA Damage; Flow Cytometry; Glutathione; Lipid Peroxidation; Male; Mice; Micronuclei, Chromosome-Defective; Razoxane; Reactive Oxygen Species; Teniposide | 2011 |